 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Other > First Horizon Pharmaceutical Corporation
 |
First Horizon Pharmaceutical Corporation |
 |
 |
 |
NEWS FROM THE WIRES |
 |
First Horizon completes purchase of vitamin line Aug 21 2001 04:54 AM PDT
First Horizon to buy Prenate line from Sanofi Aug 13 2001 09:34 AM PDT
> More WIRE STORIES about this company
PROFILE |
 |
First Horizon Pharmaceutical buys and licenses off-patent and other drugs divested by larger companies. The company's drug portfolio includes Nitrolingual, an angina treatment; Robinul, a peptic ulcer treatment; and Tanafed for allergy and cold symptoms. First Horizon has also partnered with Penwest Pharmaceuticals to develop a treatment for migraines. The company does not make the products it sells; instead, it has manufacturing agreements with the companies whose products it acquires, including American Home Products and Aventis. Major customers include McKesson HBOC, Cardinal Health, and Bergen Brunswig. Chicago-area biotech investor John Kapoor owns more than half of First Horizon.
COMPETITION |
 |
Forest Laboratories, Inc. (FRX)
King Pharmaceuticals, Inc. (KG)
Watson Pharmaceuticals, Inc. (WPI)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 36.60
1-Yr. Sales Growth: 96.5%
Employees: 178
Revenue per employee: $205,617.98
KEY PEOPLE |
 |
Mahendra G. Shah
CEO
Balaji Venkataraman
CFO
CONTACT INFO |
 |
660 Hembree Pkwy., Ste. 106
Roswell, GA 30076
US
Phone: 770-442-9707
Fax: 770-442-9594
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |